Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("LE BOUC, Y")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 73

  • Page / 3
Export

Selection :

  • and

Les Insulin-Like Growth Factors (IGFs) et leurs états protéines de liaison (IGFBP) : Régulations à l'état physiologique et en pathologie = Insulin-Like Growth Ffactors (IGFs) and their binding-proteins (IGFBP) : Regulation in physiologic and pathologic statesLE BOUC, Y.Revue médicale libanaise. 1996, Vol 8, Num 2, pp 67-71, issn 1016-6017Conference Paper

CARBOHYDRATE INTAKE AFFECTS INSULIN BINDING TO HUMAN ERYTHROCYTES IN NORMAL WEIGHT SUBJECTS BUT NOT IN SUBJECTS WITH FAMILY OBESITYRIZKALLA SW; LE BOUC Y; SEROG P et al.1981; METAB., CLIN. EXP.; ISSN 0026-0495; USA; DA. 1981; VOL. 30; NO 9; PP. 900-907; BIBL. 59 REF.Article

Anomalies de l'axe somatotrope et usage abusif d'hormone de croissance (GH) = Abnormalities of somatotrope axis and growth hormone dopingLE BOUC, Y; GUINOT, M.Science & sports. 2005, Vol 20, Num 4, pp 215-217, issn 0765-1597, 3 p.Conference Paper

Physiopathologie de l'axe somatotrope dans l'insuffisance rénale chronique = Pathophysiology of the somatotropic axis in chronic renal failureCABROL, S; HOUANG, M; LE BOUC, Y et al.Archives de pédiatrie (Paris). 1998, Vol 5, pp 348s-353s, issn 0929-693X, SUP4Conference Paper

Recent advances in the pathogenesis of adrenocortical tumoursGICQUEL, C; BERTAGNA, X; LE BOUC, Y et al.European journal of endocrinology. 1995, Vol 133, Num 2, pp 133-144, issn 0804-4643Article

Pathologie de la croissance et anomalies des gènes des IGF = Pathology of the growth and abnormalities of IGF genesSCHNEID, H; SEURIN, D; LE BOUC, Y et al.Annales d'endocrinologie. 1991, Vol 52, Num 6, pp 479-482, issn 0003-4266Conference Paper

Explorations de la fonction somatotropeRAUX DEMAY, M. C; LE BOUC, Y.MTP. Médecine thérapeutique pédiatrie. 2006, Vol 9, Num 4, pp 203-212, issn 1286-5494, 10 p.Article

Syndrome de Turner : Clinique - génétique - thérapeutique : L'hormone de croissance (2éme partie) = Turner syndrome : Clinical aspects -genetic aspects - therapyCABROL, S; BOURCIGAUX, N; GICQUEL, C et al.Revue internationale de pédiatrie. 2000, Num 302, pp 25-32, issn 0048-8135Article

Assessment of Turner's syndrome by molecular analysis of the X chromosome in growth-retarded girlsGICQUEL, C; GASTON, V; CABROL, S et al.The Journal of clinical endocrinology and metabolism. 1998, Vol 83, Num 5, pp 1472-1476, issn 0021-972XArticle

IGFs and their binding proteinsGOURMELEN, M; PERIN, L; LE BOUC, Y et al.Nuclear medicine and biology. 1994, Vol 21, Num 3, pp 297-302, issn 0969-8051Conference Paper

Phenotypic and genotypic variability in monozygotic triplets with Turner syndromeLESPINASSE, J; GICQUEL, C; ROBERT, M et al.Clinical genetics. 1998, Vol 54, Num 1, pp 56-59, issn 0009-9163Article

Ava II RFLP at the insulin-like growth factor II (IGF II) locus on chromosome 11SCHNEID, H; GIRARD, F; BINOUX, M et al.Nucleic acids research. 1989, Vol 17, Num 1, issn 0305-1048, 466 [1 p.]Article

Epigenetic and Genetic Mechanisms of Abnormal 11p15 Genomic Imprinting in Silver-Russell and Beckwith-Wiedemann Syndromes : Epigeentic Mechanisms and Therapeutic StrategiesDEMARS, J; LE BOUC, Y; EL-OSTA, A et al.Current medicinal chemistry. 2011, Vol 18, Num 12, pp 1740-1750, issn 0929-8673, 11 p.Article

Serum levels of insulin-like growth factor (IGF) and IGF binding protein in constitutionally tall children and adolescentsGOURMELEN, M; LE BOUC, Y; GIRARD, F et al.The Journal of clinical endocrinology and metabolism. 1984, Vol 59, Num 6, pp 1197-1203, issn 0021-972XArticle

Orosomucoid: a mortality risk factor in elderly people living in the community?RAYNAUD-SIMON, A; LAFONT, S; BERR, C et al.Clinical nutrition (Edinburgh). 2002, Vol 21, Num 1, pp 45-50, issn 0261-5614Article

Hormone de croissance et dopage: difficultés du dépistage = Growth hormone and dopingSOUBERBIELLE, J C; GUINOT, M; FINK, E et al.Immuno analyse & biologie spécialisée. 2001, Vol 16, Num 3, pp 183-188, issn 0923-2532Article

Le syndrome de Noonan : une énigme = Noonan syndrome : an enigmaLIMAL, J. M; BONNET, D; LE BOUC, Y et al.Archives de pédiatrie (Paris). 1998, Vol 5, Num 7, pp 715-718, issn 0929-693XArticle

Molecular diagnosis of Turner's syndromeGICQUEL, C; CABROL, S; SCHNEID, H et al.Journal of medical genetics. 1992, Vol 29, Num 8, pp 547-551, issn 0022-2593Article

Genotyping of Cre-lox mice and detection of tissue-specific recombination by multiplex PCRLENEUVE, P; ZAOUI, R; MONGET, P et al.BioTechniques. 2001, Vol 31, Num 5, pp 1156-1162, issn 0736-6205, 6 p.Article

The cortisol-cortisone shuttle in children born with intrauterine growth retardationHOUANG, M; MORINEAU, G; LE BOUC, Y et al.Pediatric research. 1999, Vol 46, Num 2, pp 189-193, issn 0031-3998Article

IGF-I et son système de régulation = IGF-1 and its regulation systemLE BOUC, Y; PERIN, L; CABROL, S et al.Archives de pédiatrie (Paris). 1996, Vol 3, pp 141s-143s, issn 0929-693X, SUP1Conference Paper

Gonadal dysgenesis in del(18p) syndromeTELVI, L; BERNHEIM, A; ION, A et al.American journal of medical genetics. 1995, Vol 57, Num 4, pp 598-600, issn 0148-7299Article

Intérêts du suivi biologique du cycliste de haut niveau dans le dépistage des insuffisances surrénaliennes post-corticothérapie = Role of plasma cortisol follow-up for the detection of glucocorticoid-induced adrenal insufficiency in elite cyclistsGUINOT, M; DUCLOS, M; MEGRET, A et al.Science & sports. 2005, Vol 20, Num 4, pp 193-196, issn 0765-1597, 4 p.Conference Paper

Anomalies du système des IGFs dans les tumeurs cortico-surrénaliennes = Involvement of the IGF system in the pathogenesis of adrenocortical tumorsGICQUEL, C; BOULLE, N; LOGIE, A et al.Annales d'endocrinologie. 2001, Vol 62, Num 2, pp 189-192, issn 0003-4266Conference Paper

Increased levels of insulin-like growth factor II (IGF-II) and igf-binding protein-2 are associated with malignancy in sporadic adrenocortical tumorsBOULLE, N; LOGIE, A; GICQUEL, C et al.The Journal of clinical endocrinology and metabolism. 1998, Vol 83, Num 5, pp 1713-1720, issn 0021-972XArticle

  • Page / 3